Citurgia Biochemicals Limited (BOM:506373)
India · Delayed Price · Currency is INR 114.10
-1.15 (-1.00%)
At close: Jul 20, 2026
Citurgia Biochemicals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 1.27 | 1.19 | 1.05 | 0.78 | 0.54 |
Short-Term Investments | - | 0.08 | 0.08 | 0.08 | 0.08 |
Cash & Short-Term Investments | 1.27 | 1.26 | 1.12 | 0.86 | 0.61 |
Cash Growth | 0.45% | 12.58% | 30.65% | 39.71% | -19.09% |
Receivables | 0.3 | 0.23 | 0.23 | 0.23 | 0.23 |
Inventory | 80.66 | 80.66 | 80.66 | 80.66 | 80.66 |
Other Current Assets | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 |
Total Current Assets | 83.24 | 83.16 | 83.02 | 82.76 | 82.51 |
Property, Plant & Equipment | 3.96 | 6.21 | 8.47 | 10.72 | 12.98 |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 |
Other Long-Term Assets | -0 | 5.43 | 5.43 | 5.43 | 5.43 |
Total Assets | 104.7 | 107.64 | 110.41 | 111.91 | 114.28 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 36.31 | 36.31 | 36.31 | 36.31 | 36.31 |
Accrued Expenses | 5.1 | 0.43 | 0.48 | 0.55 | 0.57 |
Short-Term Debt | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 |
Current Income Taxes Payable | - | 4.9 | 4.9 | 4.9 | 4.9 |
Other Current Liabilities | 53.39 | 49.3 | 48.44 | 47.28 | 45.83 |
Total Current Liabilities | 95.14 | 91.28 | 90.47 | 89.38 | 87.95 |
Long-Term Debt | 68.63 | 68 | 67.36 | 65.18 | 64.62 |
Long-Term Deferred Tax Liabilities | 17.11 | 17.11 | 17.11 | 17.11 | 17.11 |
Other Long-Term Liabilities | 1.17 | 1.17 | 1.17 | 1.17 | 1.17 |
Total Liabilities | 182.05 | 177.56 | 176.1 | 172.84 | 170.85 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 264.19 | 264.19 | 264.19 | 264.19 | 264.19 |
Retained Earnings | - | -359.84 | -355.61 | -350.86 | -346.49 |
Comprehensive Income & Other | -341.53 | 25.74 | 25.74 | 25.74 | 25.74 |
Shareholders' Equity | -77.34 | -69.92 | -65.69 | -60.93 | -56.57 |
Total Liabilities & Equity | 104.7 | 107.64 | 110.41 | 111.91 | 114.28 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 68.97 | 68.34 | 67.7 | 65.52 | 64.96 |
Net Cash (Debt) | -67.7 | -67.07 | -66.57 | -64.66 | -64.34 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | - | -0.51 | -0.50 | -0.49 | -0.49 |
Filing Date Shares Outstanding | - | 132.1 | 132.1 | 132.1 | 132.1 |
Total Common Shares Outstanding | - | 132.1 | 132.1 | 132.1 | 132.1 |
Working Capital | -11.9 | -8.12 | -7.45 | -6.63 | -5.44 |
Book Value Per Share | - | -0.53 | -0.50 | -0.46 | -0.43 |
Tangible Book Value | -77.34 | -69.92 | -65.69 | -60.93 | -56.57 |
Tangible Book Value Per Share | - | -0.53 | -0.50 | -0.46 | -0.43 |
Land | - | 0.14 | 0.14 | 0.14 | - |
Buildings | - | 2.29 | 2.29 | 2.29 | 2.29 |
Machinery | - | 61.63 | 61.63 | 61.63 | 61.63 |